Astera Labs designs connectivity semiconductors — the retimers, smart cables, fabric switches and CXL memory controllers that move data reliably between the GPUs, CPUs and memory inside AI and cloud servers. Its flagship Aries PCIe/CXL Smart Retimers are the reference-design choice at most hyper-scale AI server platforms, unified by a software layer (COSMOS) that lets operators manage and diagnose connectivity across a fleet. In plain terms, if AI accelerators are the engines of a data centre, Astera makes the high-speed “nervous system” wiring that keeps them fed with data. Founded in 2017 and public since March 2024, it is a small (~$54bn cap, ~750-employee) fabless specialist whose edge is being first and software-rich on each new PCIe/CXL generation — though it competes with far larger rivals (Broadcom, Marvell) and a pure-play peer (Credo).
Lifecycle & sector. Astera Labs is a fabless semiconductor company (GICS Technology · Semiconductors) in the High-Growth stage: TTM revenue of ~$1.00bn is compounding at +93% YoY with a 76% gross margin and GAAP profitability that only turned positive in 2024. We therefore score it on the high-growth semi lens — revenue trajectory, gross margin, operating leverage, a Rule-of-40-style composite and balance-sheet quality — not on trailing P/E, which is meaningless at this stage of the curve.
| Sub-signal | ALAB | Sector / context | Score | Read |
|---|---|---|---|---|
| Revenue trajectory | +93% YoY; +14% QoQ (Q1'26 $308.4m) | Semis median mid-single-digit; hyper-scaler AI names 30-60% | 92 | Top-decile top-line; four straight sequential records |
| Gross margin | 76.0% TTM | Fabless strong >60%; Broadcom ~75%, Marvell ~60% | 88 | Best-in-class fabless margin; IP/software mix |
| Operating margin (GAAP) | 22.4% TTM ($224m) | Improving from ~14% a year ago | 78 | Operating leverage building as revenue scales past R&D |
| Cash generation | FCF $240m TTM (24% margin) | Positive and rising | 80 | Capital-light fabless; capex only ~$0.24/sh |
| Balance sheet | Cash $1.18bn, debt $42m; current ratio 11.3x | Net cash ~$1.14bn | 95 | Fortress; zero refinancing risk (ROE 21%, ROA 10%) |
| Earnings quality | Net income $267.6m > operating income $224.0m | Interest income ~$45.9m = 17% of net income | 60 | Reported net flattered by interest income + tax swings — see §4 |
Design-win lock-in supports price, but merchant rivals cap it
Limited; some COSMOS software / fleet-telemetry data flywheel
Sticky within a platform generation, but re-competed each new PCIe gen
Fabless scale, but smaller than Broadcom/Marvell
COSMOS software, PCIe/CXL IP depth, first-mover on Gen6
Moat average ~62. The walls are real but not deep: Astera's edge is being first and software-rich in a fast-moving connectivity standard, not an un-assailable structural lock. The switching-cost and cost-advantage scores are deliberately derived from the competitive read below, not asserted.
| Rival | Threat type | Share trajectory (ALAB vs rival) | Moat-erosion vector |
|---|---|---|---|
| Broadcom (AVGO) | Merchant incumbent, vastly larger R&D | ALAB leads today; rival closing the Gen-6 hardware gap | Bundling connectivity with switch/SerDes franchises; parity erodes pricing power |
| Marvell (MRVL) | Merchant incumbent, custom + connectivity | ALAB leads; rival investing hard in PCIe/CXL + custom | Attach connectivity to custom-ASIC hyper-scaler wins |
| Credo (CRDO) | Specialised pure-play | Contested; Credo's Dakota/Odin in production at cloud OEMs | Direct PCIe 5/6 retimer competition on price and design-win slots |
| Hyper-scaler in-house | Vertical substitution / insourcing | Risk, not yet realised at scale | Customers designing their own connectivity IP for custom fabrics |
Net effect on the moat: currently gaining share and broadening (Scorpio fabric switches, Leo CXL, Taurus, scale-up/UALink optionality), but the threat level is elevated — two rivals with far bigger balance sheets are converging on Gen-6. That caps Switching Costs at 66 and Cost Advantage at 55, and it feeds the §11 bear (share/margin loss) and the §12 thesis-invalidation floor. competitive_threat_level: elevated.
Capital-light fabless economics: on operating invested capital (excluding the ~$1.18bn cash pile) operating ROIC is very high (well above cost of capital). Capital allocation is 100% reinvestment — no dividend, no buyback — appropriate at this stage, funded by internal cash and IPO proceeds. Skin in the game: founder-led (CEO Jitendra Mohan), meaningful insider ownership post-2024 IPO. The one real drag is stock-based compensation, high as a share of revenue as is typical for a young fabless company (see the Gate 4 caution in §2) — diluted share count crept ~2.3% annualised over the last year, below the 5% red-line but worth watching.
Bottom line: expensive, decisively. On every disciplined lens Astera trades far above what its rate-and-growth fundamentals warrant. This is a very good business at a very demanding price.
| Multiple | ALAB | Warranted / guardrail | Read |
|---|---|---|---|
| Forward P/E (NTM) | ~68x | Warranted 27.5x; guardrail 28x | 2.5x warranted — Expensive |
| P/E on 2026 est ($3.03) | ~105x | — | Extreme |
| P/E on 2027 est ($4.71) | ~67x | — | Still >2x guardrail |
| EV / Revenue (TTM) | ~50x | IT rich line ≥20x | 2.5x the rich line |
| EV / Revenue (fwd 2026) | ~32x | ≥20x rich | Expensive |
| Price / Sales (TTM) | ~54x | — | Very rich |
| Price / Book | ~36x | — | Rich |
| FCF yield (FCF/EV) | 0.48% | >8% very attractive; <1% very expensive | Not yet a cash-return story |
Earnings-quality decomposition (step 7b). Reported TTM net income of $267.6m exceeds operating income of $224.0m — the gap is interest income (~$45.9m, ~17% of net income) on the $1.18bn cash pile plus a volatile tax line (a $24m benefit one quarter, a $34m expense the next). So reported net margin (26.7%) overstates operating profitability (22.4%), and the trailing P/E is if anything understated versus a clean operating basis (clean operating EPS ~$1.24 vs reported diluted $1.48). The distortion doesn't rescue the valuation — on clean operating earnings the multiple is worse, not better. nonop_pct_of_net_income ≈ 17%.
Reverse-DCF / implied growth. At $317 the market is embedding roughly 30%+ sustained free-cash-flow growth for a decade to justify the price on our disciplined discount rate — well above the 15% secular-cap we will underwrite and above even the disciplined-haircut consensus. The price embeds more growth than the fundamentals support; the burden of proof is on flawless multi-year execution.
Analyst cross-check. 22 analysts; consensus/mean target $300, median $275, high $475, low $155. The current $317 sits above the median and the last-quarter average ($276.73) and just above the last-month average ($300) — i.e. the stock has run past where the Street thinks it should be, even as targets have climbed all year ($172 → $236 → $277 → $300). Grades: 13 Buy / 5 Hold / 0 Sell (72% bullish) — solid conviction but not unanimous. FMP financial-health rating B (3/5): ROE 4/5, ROA 5/5, D/E 4/5 (quality confirmed) but DCF 1/5, P/E 1/5, P/B 1/5 (valuation flagged) — an independent echo of “great business, rich price.”
Primary driver: the AI / data-centre capex cycle — specifically hyper-scaler spending on AI server infrastructure, which pulls Astera's PCIe/CXL connectivity content per rack. This sits above the company's own execution: however well Astera runs, its revenue is geared to how much Amazon, Microsoft, Google, Meta and the neoclouds spend on AI build-out.
| Horizon | Read | Assessment |
|---|---|---|
| Historical (25%) | AI-capex boom 2024-26; hyper-scaler capex at successive records; PCIe6/CXL ramp beginning | Strong (90) |
| Current (50%) | Capex still at record levels; AI server builds robust; but the macro report flags an armed AI-concentration / earnings-quality tail | Favourable (82) |
| Forward (25%) | Consensus still sees capex growth into 2027 but decelerating; digestion / “air-pocket” risk is the debate | Constructive (70) |
Driver score = 0.25·90 + 0.50·82 + 0.25·70 = 81 → Strong Tailwind. A score ≥65 makes the name eligible to amplify a base BUY to STRONG BUY — but the base signal here is HOLD, which never amplifies, so the tailwind changes nothing about the signal. It does frame the bull case. Per horizon the tailwind is strongest long (secular AI-connectivity content growth), still positive medium (capex growth but decelerating + the concentration tail), and positive-but-event-heavy short (the Aug 4 print is the near-term referendum).
The 30 Jul macro report (regime: Stagflation-lite — energy shock re-armed, policy-tight into cooling growth) rates XLK Neutral (short) / Underperform (medium) / Outperform (long). Anchoring on the medium horizon, the economic pressure is a Headwind — rate-tightness and the ARMED S&P-concentration / AI-earnings-quality tail weigh on richly-valued tech into H2, even as the long-run AI-capex tailwind keeps XLK Outperform on a 6-18m view. Going long here is therefore Contrarian (fighting the medium headwind), and conviction is low (38) because the case has no valuation washout (the name is Expensive, not oversold) to justify fading the macro. Because the pressure is Headwind (not Tailwind), it cannot enable a STRONG BUY — and with a HOLD base signal, amplification is moot. Short pressure is Neutral (XLK short N); long pressure is a Tailwind (XLK long O) but does not lift an Expensive-capped HOLD.
Source: sector-map (GICS Technology → XLK; ALAB not a macro watchlist name) · Macro report 2026-07-30
Timing is genuinely mixed — a higher-timeframe uptrend with a broken-down daily chart and a binary earnings print four days out. That combination scores Neutral, which under the short-term 55% timing weight is what keeps the near-term read from being constructive despite today's bounce.
| Sub-signal | Read | Score |
|---|---|---|
| MTF trend (30%) | Monthly & weekly uptrend (RSI 63/57, above EMAs); daily weakening + support breakdown (RSI 44, price below 20/50-DMA at $341/$354, above 200-DMA $207); hourly bounce today | 65 |
| Risk-reward (20%) | Bounced off ~$300; nearest daily support $303/$290; next real support far below (gap to ~$190); overhead 20/50-DMA at $341/$354. ATR $36 (11%/day, beta 3.67) | 50 |
| Relative strength | ~-33% YTD, -36% off the 52-wk high $499; 52-wk range position ~55%. Underperforming SPY/XLK over 3m; only a 1-month bounce | 32 |
| Macro overlay (15%) | Semis = medium macro sensitivity; XLK short Neutral / medium Underperform; Fed on-hold-and-tight (stagflation-lite) | 45 |
| Sentiment (18%) | Targets climbing all year; Cramer “buy” (29 Jul); 13 Buy/5 Hold — but price is above consensus | 60 |
| Catalyst (17%) | Q2 earnings 4 Aug (4 days) clustered with core-PCE (31 Jul) & the Aug-1 tariff deadline — noisy, high path risk | 35 |
Composite Timing ≈ 52 (Neutral). Confidence is capped by the imminent earnings (binary event, ALAB routinely moves 10-20% on prints) — see the Earnings-Event gate in §2.
Reading it: the primary (monthly/weekly) trend is still up and the stock has already de-rated ~36% from its high, but the tactical daily chart broke support and the single biggest near-term event is unresolved. This is not a “buy the dip in an uptrend” with confirmation — it is a coin-flip into a print. Neither the Technical nor the Catalyst entry group is met (see §12), so even setting valuation aside there is no confirmed timing edge right now.
| Date | Event | Impact | Forecast | Previous | Relevant? | Why |
|---|---|---|---|---|---|---|
| 2026-07-31 | Core PCE (Jun) | High | 2.9% y/y | 2.9% | ⚠ Medium | Sets the Fed path / growth-multiple discount rate; matters to long-duration semis |
| 2026-08-01 | Tariff-wall deadline | High | — | — | ⚠ Medium | Supply-chain / China semi trade risk; cost + demand read-through |
| 2026-08-04 | ALAB Q2 2026 earnings | High | Rev $355-365m | $308.4m | ✅ Yes | Binary company event — the near-term referendum on the AI-connectivity ramp |
| 2026-08-01 | ISM Manufacturing (Jul) | Medium | — | — | ⚠ Medium | Chip-demand cycle proxy |
| Date | Event | Actual | Forecast | Surprise | Impact |
|---|---|---|---|---|---|
| 2026-07-29 | Cramer “lightning round” | Buy ALAB | — | + | Sentiment: mildly positive |
| 2026-07-30 | Mega-cap/XLK tape | MSFT/XLK +5.5% | — | narrow | AI names ripped while RSP flat — the concentration tell |
The dominant near-term event is Astera's own 4 Aug Q2 print, clustered with core-PCE (31 Jul) and the 1 Aug tariff deadline. Semis are medium-macro-sensitivity, so the PCE/tariff pair is a secondary volatility source; the earnings report is the primary one. Guidance calls for $355-365m revenue (+15-18% QoQ) and non-GAAP EPS $0.68-0.70 — a beat-and-raise would fire the §12 Catalyst group, a guide-down would arm the bear leg. Position for path risk, not a directional edge, into the print.
| Timeframe | Trend | Direction | RSI | MACD | Key S/R | Breakout | Vol |
|---|---|---|---|---|---|---|---|
| Monthly | Uptrend ↑ | Bullish | 63 | +, high | S $132 / R $263 | Resist. breakout | 0.9x |
| Weekly | Uptrend ↑ | Bullish | 57 | +, flat (49.5/50.1) | S $131 / R $263-499 | Resist. breakout | 0.9x |
| Daily | Weakening → | Bearish | 44 | -, falling (-25/-15) | S $303/$290 / R $372 | Support breakdown | 1.4x |
| Hourly | Uptrend ↑ | Bullish | 63 | -, turning | S $305 / R $342 | Bounce today | 0.6x |
| 15-min | Weakening → | Neutral | 53 | +, small | S $305-315 / R $342 | — | 0.1x |
| Confluence: Mostly Bullish (higher TFs up, daily broken) · MTF Score ~65 | |||||||
Textbook divergence: the monthly and weekly frames are in clean uptrends (price above rising EMAs, both flagged resistance-breakout), but the daily chart — where tactical entries are decided — broke support and sits below its 20- and 50-day averages with a falling MACD (RSI 44). Price is still ~53% above the 200-DMA ($207), so the secular uptrend is intact; this is a short-term pullback within a larger advance, unresolved into the 4 Aug print. Key levels: reclaim the 50-DMA (~$354) to repair the daily; lose $290 on a close and the next real support is a long way down (~$190).
6-month daily (illustrative). Price pulled back ~36% from the $499 high to ~$300, bounced to $317; below the falling 50-DMA (~$354), well above the 200-DMA (~$207). Support $290-$303, then a gap toward ~$190.
The AI-capex supercycle runs uninterrupted: Astera holds its Gen-6 retimer lead, Scorpio fabric switches and scale-up/UALink content compound content-per-rack, and it beats-and-raises through 2026-27. The market keeps paying a premium multiple (~65-70x forward). Retests the prior 52-wk high / Street-high target ~$475 (+50%). Requires flawless execution AND a sustained AI-capex tape AND breadth staying narrow-but-up.
Astera executes — growth decelerates from ~90% toward 40-50% as it laps tough comps — but the hyper-growth multiple compresses modestly (68x toward ~55x) as the market normalises AI-semi valuations. The stock oscillates around the analyst consensus band ($275-320), i.e. roughly flat-to-slightly-down from $317 over 12 months (~$300, -5%). This is the probability-weighted centre of gravity and the reason the signal is HOLD: a great business already priced for it.
The AI-concentration de-rating leg (inherited from the macro report's ARMED tail). Two forces compound: (1) COHORT-LEVEL multiple compression — a hyper-scaler capex guide-down or a private-AI valuation markdown de-rates the whole AI-capex cohort, taking Astera's forward multiple from ~68x toward ~35-40x (a 45-50% multiple move on its own); PLUS (2) company-specific — Broadcom/Marvell take Gen-6 retimer share and customer concentration bites. Combined target ~$185 (-42%), still above the extreme 52-wk low of $98. Trigger: AI-capex guide-down / private-AI markdown / a rival Gen-6 design-win sweep. Falsification: index breadth broadens (RSP catches SPY) and the concentration tail disarms.
Probability-weighted fair value ≈ $321 (0.25·475 + 0.55·300 + 0.20·185) — almost exactly today's $317. That is the tell: the market is fairly pricing the probability tree, but the asymmetry is poor (a 25% shot at +50% against a 20% shot at -42%, with the 55% base slightly negative), and the disciplined warranted-multiple fair value (~$200) sits well below spot. Fully priced, thin margin of safety, into an armed cohort-de-rating tail — which is why the base HOLD is overridden to DO NOT BUY for new capital.
Forecast: Rule Forecast. Fundamental — UNLIKELY without a ~35%+ drawdown to the ~$200 warranted-fair-value zone; at current trajectory not in view (would need the bear leg). Technical — MODERATE/event-dependent: a reclaim of the $354 50-DMA is ~12% away and gated by the 4 Aug print; a confirmed higher-low bounce off $290-$300 could set up within 1-2 weeks IF the print is taken well. Catalyst — CATALYST-DEPENDENT on the 4 Aug Q2 report (guide $355-365m, +15-18% QoQ; non-GAAP EPS $0.68-0.70): a beat-and-raise with a >+5% move on >2x volume would fire this group and lift the size ladder to Half-Size — but the ladder sets size, not permission: the signal is DO NOT BUY (Valuation-Ceiling + DNB Trigger 2(b)), so a fired Catalyst group changes nothing until the price de-rates or the armed tail disarms.
Forecast: No exit trigger is live today (not held). The stop at $285 is ~10% below spot (~0.8 ATR); the 4 Aug print is the obvious gap-risk event either way.
What you're risking: the stock is Expensive (68x forward vs a 27.5x warranted multiple), the Valuation-Ceiling gate caps it at HOLD, and DNB Trigger 2(b) then overrides to DO NOT BUY (Expensive + an armed AI-concentration tail with narrowing breadth); you'd be buying above the analyst consensus ($275-300), below no support until ~$190, into a binary Q2 print in 4 days on a beta-3.67 name (ATR ~11%/day). Neither the Technical nor Catalyst entry group is met.
What you're gaining: immediate participation in a best-in-class AI-connectivity franchise with a strong-tailwind driver and real embedded optionality (Scorpio, UALink, CXL). But the base case is slightly negative and the probability-weighted fair value (~$321) ≈ today's price. Read: acting now buys a fully-priced name ahead of its biggest event — waiting for the print and/or a pullback into the $290-$300 (or ideally the ~$200 warranted) zone materially improves the deal.
What you're giving up: the base-to-bull path ($300-$475) and the optionality/compounding of a category leader, and you'd be exiting a top-quality business on price alone.
What you're protecting: capital against the cohort de-rating leg if the AI-capex tape cracks. For a would-be buyer the signal is DO NOT BUY (don't initiate). For an existing holder, note that no mechanical exit rule is live (no stop hit, no thesis break, not at target), so an owner is in a trim-into-strength / tighten-stops zone rather than a forced sell — the DO NOT BUY governs new capital, not a panic exit.
Position sizing not computed — specify your portfolio allocation and role for sizing guidance.
{
"ticker": "ALAB",
"date": "2026-07-31",
"version": "v6",
"brand": "Astera Labs",
"company": "Astera Labs, Inc.",
"currency": "USD",
"exchange": "NASDAQ",
"exchange_ticker": "NASDAQ:ALAB",
"isin": "US04626A1034",
"api_ticker": "ALAB",
"finder_ticker": "ALAB",
"finder_exchange": "NASDAQ",
"analysis_status": "starting",
"user_context": {
"horizon": null,
"allocation_pct": null,
"portfolio_role": null
},
"user_horizon": null,
"user_allocation_pct": null,
"portfolio_role": null,
"price_at_rating": 317.29,
"signal_short": "DO_NOT_BUY",
"signal_medium": "DO_NOT_BUY",
"signal_long": "DO_NOT_BUY",
"primary_signal": "DO_NOT_BUY",
"short_hold_reason": "expensive",
"short_entry_confirmed": false,
"short_cap_reason": "Base HOLD (Expensive); Valuation-Ceiling caps at HOLD; DNB Trigger 2(b) then overrides to DO NOT BUY; neither Technical nor Catalyst entry group met",
"quality_score": 78,
"lifecycle_stage": "high-growth",
"quality_detail": {
"industry_benchmark_name": "Semis (Gross Margin + demand)",
"industry_benchmark_value": 76,
"industry_benchmark_score": 86,
"moat_score": 62,
"roic_percentile_vs_peers": 85,
"capital_allocation": 70,
"management_skin_in_game": 62
},
"valuation_score": 29,
"valuation_detail": {
"fcf_yield": 0.48,
"implied_growth_rate": 30.0,
"consensus_growth_rate": 46.0,
"historical_valuation_decile": 8
},
"warranted_multiple": 27.5,
"actual_multiple": 68.0,
"val_multiple_basis": "forward P/E (NTM)",
"discount_rate_r": 9.17,
"risk_free_10y": 4.67,
"g_near": 15.0,
"g_term": 3.0,
"warranted_ratio": 2.47,
"val_band": "expensive",
"timing_score": 52,
"timing_detail": {
"mtf_confluence": 65,
"risk_reward_score": 50,
"relative_strength_vs_spy": -33.0,
"relative_strength_vs_sector": -30.0,
"catalyst_clustering_score": 35,
"dynamic_macro_weight": 0.15
},
"driver_score": 81,
"driver_label": "Strong Tailwind",
"nonop_pct_of_net_income": 17.0,
"clean_pe": 256.0,
"clean_peg": null,
"competitive_share_trajectory": "gaining",
"competitive_threat_level": "elevated",
"economic_alignment_stance": "Contrarian",
"economic_alignment_conviction": 38,
"economic_alignment_pressure": "Headwind",
"economic_alignment_source": "sector-map",
"macro_report_date": "2026-07-30",
"overall_confidence": 50,
"fair_value_est": 200.0,
"stop_loss": 285.0,
"target_price": 300.0,
"scenario_base_target": 300,
"scenario_bull_target": 475,
"scenario_bear_target": 185,
"analyst_consensus_target": 300.0,
"analyst_target_high": 475.0,
"analyst_target_low": 155.0,
"analyst_target_median": 275.0,
"analyst_target_upside_pct": -5.4,
"analyst_grades_consensus": "Buy",
"analyst_bullish_pct": 72.2,
"analyst_coverage_count": 22,
"fmp_rating": "B",
"fmp_overall_score": 3,
"recent_upgrades_30d": null,
"recent_downgrades_30d": null,
"entry_groups_met": 0,
"entry_conviction": "Wait",
"exit_groups_live": 0,
"exit_action": "Hold",
"hard_gate_state": "donotbuy",
"gates_triggered": [
"Valuation Ceiling"
],
"gates_caution": [
"Earnings Event Risk",
"Accounting / Dilution"
],
"do_not_buy_triggers": [
"Trigger 2 (Valuation Extreme) arm (b): Expensive band (68x fwd vs 27.5x warranted) + armed AI-concentration systemic tail (breadth narrowing, RSP flat while XLK ripped), genuine cohort member"
],
"dnb_trigger2_armed": true,
"dnb_trigger2_fired": true,
"dnb_trigger2_note": "arm (b) FIRES: Expensive + genuine AI cohort + macro tail armed with breadth narrowing (not broadening) -> overrides capped HOLD to DO NOT BUY; consistent with the prior 2026-07-16 report",
"next_update_date": "2026-08-05",
"next_update_basis": "earnings 2026-08-04 +1 trading day",
"next_check_date": "2026-08-05"
}